Quanterix Launches First PTau-181 Plasma Laboratory Developed Test For Clinical Diagnostic And Research Applications In The U.S.
Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced the validation of a laboratory developed test (LDT) to quantitatively measure phospho-Tau 181…